Investors worry that anti-obesity drugs could dent demand for medical procedures and devices.  Here’s what they could be missing.

Will Anti-Obesity Drugs Disrupt the MedTech Industry?

Short, thoughtful and regular takes on recent events in the markets from a variety of perspectives and voices within Morgan Stanley.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Midyear Economic Outlook: Reasons for Optimism

Our Head of Corporate Credit Research explains why the debt of high-rated EM countries is a viable alternative for investors looking for high yields with longer duration.

Seeking Better Value in Emerging Market Debt

Our research shows travelers are willing to spend more this summer than last. U.S. Thematic Strategist Michelle Weaver explains how this will impact the airline, cruise and lodging industries.

Get Ready for a Summer Travel Boom

Our Global Head of Fixed Income and Thematic Research explains that the Biden administration’s new tariffs on Chinese imports are narrower than those of 2018 and 2019, but still send a signal about the economic relationship between the US and China.

The Narrow Scope of US Tariffs on China

Our Retail Analyst discusses the key strategies that have propelled a select few companies in U.S. consumer retail amid a challenging demand backdrop.

Will Anti-Obesity Drugs Disrupt the MedTech Industry?

Download our free app to listen on your phone